• Amobarbital, Urine
  • Bartonella Antibody, IgG, Serum
  • Hepatitis B Core Antibody, IgG
  • Beta-Glucuronidase, Fibroblasts
  • Lysosomal Acid Lipase, Enzyme Activity
  • Methicillin-Resistant Staphylococcus aureus (MRSA) by Molecular Method
  • Temazepam, Urine
  • Listeria Antibody, Serum
  • Comprehensive Metabolic Panel
  • B-Cell Lymphoma, FISH, Bone Marrow
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

Specimen Collection
Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.